Research Concepts Flashcards

1
Q

Retrospective Studies

A
  • Looking back at data already collected.
  • Tend to miss data.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prospective Studies.

A

Collect data as study goes on

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Experimental Study

A

You are manipulating something to get information.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Observational Study

A
  • Simply looking at data, not actually manipulating anything to get information.
  • Cannot make claims about causation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are Case Control studies, what do they look at, and what measure of statistics is used.

A
  • Compare case (has disease) with control (doesn’t have disease).
  • Cannot tell prevalence as you are selecting cases so prevalence artificially high.
  • Tend to be experimental studies.
  • Looking at “What is the Frequency of exposure? in those with disease and those without disease.
  • Use Odds Ratio.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cohort Study

A
  • Take cohort as it comes, you aren’t selecting particular cases with disease.
  • Reflects true prevalence.
  • Tend to be observational studies.
  • Looking at “Is the outcome occuring?” in those exposed and those not exposed.
  • Use Relative Risk.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Null hypothesis (Ho)

Needs finishing

A
  • Mutually exclusive to the working hypothesis.
  • E.g. Null = The person is not guilty vs
    Working = The person is guilty.
  • Study wants to show evidence to falsify the null hypothesis so the null is rejected. If the null is rejected, what is left is that the working hypothesis is true.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Confidence interval

Needs finishing

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Estimation

Needs finishing

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inference

Needs finishing

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Intention to Treat

A
  • Analysis includes all participants, no matter if they completed trial or not.
  • Use if wanting to know if clinician should use treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Per protocol Design

A
  • Analysis only includes participants who complete trial.
  • Use if wanting to know mechanism of drug (i.e. need people who have completed treatment).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Descriptive statistics

A
  • Describe the sample data.
  • Reduce many numbers down –> fewer numbers.
  • E.g. mean, median, standard deviation.
  • Sample statistics.
  • Use english letters (e.g. M, SD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inferential statistics

A
  • Use sample statistics to predict population parameters.
  • Use greek letters (e.g. mu, delta).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Independent variable

Needs finishing

A

The proposed cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dependent variable

Needs finishing

A
17
Q

Variability

Needs finishing

A

We assume the sample is randomly chosen from population BUT this doesn’t happen, therefore, sample statistics will not exactly match population parameters –> sampling variability.
Need to take this variablility into account = inferential statistics.

18
Q

Parameter Estimates

Needs finishing

A

Use sample statistic to estimate population parameter.
E.g. sample mean is an estimate of population mean.
Confidence interval is one method.

19
Q

Fishers p

Needs finishing

A

p (D | Ho)

probability of the data under the null

20
Q

Fisher’s p value

Needs finishing

A
  • Index of the probability of observing the data if we assume the null hypothesis is true.
  • Long run probability of observing data at least that extremeif we reapete the experiment over and over again
  • Something rare has happened that is unexpected –> this is ‘significant’
  • a small p value = something very unlikley has happened, the null hypothesis is…
21
Q

Neyman-Pearce p value

Needs finishing

A
22
Q

Neyman-Pearson p value:
Decisions

Needs finishing

A

Correctly reject the null hypothesis (

23
Q

Type 1 error

Needs finishing

A
  • Incorrectly reject the null hypothesis –> accept working hypothesis.
  • The probability is the alpha-level (usually 0.05).
  • False positive (e.g tell a male he is pregnant or e.g use a drug which is ineffective or has adverse effects).
  • Due to P value.
24
Q

Type 2 error

Needs finishing

A
  • Incorrectly retain the null hypothesis –> working hypothesis is rejected.
  • The probability is the beta level (often 0.2).
  • False negative (e.g tell a pregnant women she isn’t pregnant or e.g. don’t use a drug which is effective for a particular disease).
  • Due to Statistical power i.e. sample size.
25
Q

Confidence intervals

Needs finishing

A
  • We can be 95% confident that the true parameter sits between these two values.
  • If we repeated the procedure (maths calculation to get confidence interval) many times over again, the confidence interval would capture the true value. 95% of the time.
  • Never the probability of the parameter having a certain value.
26
Q

Relative risk (risk ratio)

Needs finishing

A

ratio of the probability of outcome in one group to the probability of the outcome in another group
RR = (TE / (TE + TN)) / (CE / (CE + CN))
TE = treatment with events.
TN = treatment, non-events.
CE = control with events.
CN = control, non-events

RR = 1 =

27
Q

What are the Canadian Task force Level of evidence?

A

I: At least 1 RCT with proper randomisation.
II.1: Well designed cohort of case-control study.
II.2: Time series comparison or dramatic results from uncontrolled studies.
III: Expert opinion.

28
Q

What are the levels of evidence from Sackett?

A

I: Large RCTs with clear cut results.
II: Small RCTs with unclear results.
III: Cohort and case-control studies.
IV: Historical cohort or case-control studies.
V: Case series, studies with no controls.

29
Q

What are the levels of evidence for Prognostic studies?

A

I: High quality prospective cohort study with adequate power or systemic review of these studies.
II: Lesser quality prospective cohort, retrospective cohort study, untreated controls from RCT, or systematic review of these studies.
III: Case-control study or systematic review of these studies.
IV: Case series.
V: Expert opinion, case report or clinical example, or evidence based on physiology, bench research or “first principles”.

30
Q

What are the levels of evidence for therapeutic studies?

A

1A: Systematic review (with homogeneity) of RCTs.
1B: Individual RCT (with narrow confidence intervals).
1C: All or none study.
2A: Systematic review (with homogeneity) of cohort studies.
2B: Individual cohort study (including low quality RCT e.g. < 80% follow-up).
2C: “Outcomes” research, ecological studies.
3A: Systematic review (with homogeneity) of case-control studies.
3B: Individual case-control study.
4: Case series (and poor quality cohort or case-control study).
5: Expert opinion without explicit critical appraisal or based on physiology bench research or “first principles”.

31
Q

What are the Grade Practice Recommendations?
-Grade A

A
  • Strong recommendation.
  • Level I evidence or consistent findings from multiple studies of levels II, III or IV.
  • Clinicians should follow a strong recommendation unless a clear and compelling rationale for an alternative approach is present.
32
Q

What are the Grade Practice Recommendations?
-Grade B

A
  • Recommendation.
  • Levels II, III or IV evidence and findings are generally consistent.
  • Generally clinicians should follow a recommendation but should remain alert to new information and sensitive to patient preferences.
33
Q

What are the Grade Practice Recommendations?
-Grade C

A
  • Option.
  • Levels II, III, or IV evidence, but findings are inconsistent.
  • Clinicians should be flexible in their decision-making regarding appropriate practice, although they may set bounds on alternatives; patient preference should have a substantial influencing role.
34
Q

What are the Grade Practice Recommendations?
-Grade D

A
  • Option.
  • Level V evidence: little or no systematic empirical evidence.
  • Clinicians should consider all options in their decision making and be alert to new published evidence that clarifies the balance of benefit vs harm; patient preference should have a substantial influencing role.